A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.
Part of paid clinical trials in Anaheim, California.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT07283263
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Healthy Volunteers
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- BMS-985521 — DRUGSpecified dose on specified days.
- Placebo — OTHERSpecified dose on specified days
Study Details
The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986521 following single and multiple ascending doses of BMS-986521 in healthy adult participants, and to evaluate potential food effects on BMS-986521 exposure.
Key Dates
- Start date
- Dec 23, 2025
- Status verified
- Jan 2026
- Primary completion
- Nov 17, 2026
- Completion
- Nov 17, 2026
Study Design
- Enrollment
- 106 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Part A Cohort 1
- Experimental: Part A Cohort 2
- Experimental: Part A Cohort 3
- Experimental: Part A Cohort 4
- Experimental: Part A Cohort 5
- Experimental: Part A Cohort 6
- Experimental: Part B Cohort 7
- Experimental: Part B Cohort 8
- Experimental: Part B Cohort 9
- Experimental: Part B Cohort 10
- Experimental: Part B Cohort 11
- Experimental: Part C
Primary Outcome Measure
Number of participants with treatment-emergent adverse events (AEs) [ Time Frame: Up to approximately Day 40 ]
Central Contacts
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com855-907-3286
- First line of the email MUST contain the NCT# and Site #.
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CenExel ACT (Formerly Anaheim Clinical Trials; LLC) | Anaheim | California | 92801 | Peter Winkle, Site 0001 949-295-7809 |
Find similar trials in Anaheim, CA
By research site
Related Studies
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)PHASE1/PHASE2 · Recruiting · Regeneron Pharmaceuticals · Glendale, California
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseasePHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Birmingham, Alabama
- Blood Flow Restriction Training on Upper Extremity Grip StrengthRecruiting · Casa Colina Hospital and Centers for Healthcare · Pomona, California
- A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaPHASE1 · Recruiting · Novo Nordisk A/S · Glendale, California